Brain Tumor Drugs Market was estimated at US$ 2.9 billion in 2022 and is expected to reach US$ 5.73 billion by 2030. and is anticipated to increase at a CAGR of 8.9% predicted for the forecast period of 2022-2030. This promising growth is fueled by a multitude of factors: Rising awareness and diagnosis: Increased understanding of brain tumors and advances in diagnostic tools are leading...